MeSH Review:
Hepatitis C
Hinrichsen,
Benhamou,
Wedemeyer,
Reiser,
Sentjens,
Calleja,
Forns,
Erhardt,
Crönlein,
Chaves,
Yong,
Nehmiz,
Steinmann,
Frank,
Mohamed,
Strickland,
Lavanchy,
Arthur,
Magder,
El Khoby,
Abdel-Wahab,
Aly Ohn,
Anwar,
Sallam,
Poynard,
Marcellin,
Lee,
Niederau,
Minuk,
Ideo,
Bain,
Heathcote,
Zeuzem,
Trepo,
Albrecht,
Dolan,
Shearer,
White,
Zhou,
Kaldor,
Wodak,
Anderson,
Daifuku,
Loeb,
Samuel,
Bizollon,
Feray,
Roche,
Ahmed,
Lemonnier,
Cohard,
Reynes,
Chevallier,
Ducerf,
Baulieux,
Geffner,
Albrecht,
Bismuth,
Trepo,
- The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Crotty, S., Maag, D., Arnold, J.J., Zhong, W., Lau, J.Y., Hong, Z., Andino, R., Cameron, C.E. Nat. Med. (2000)
- Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K., Sata, M., Kohara, M., Yoshimura, A. J. Exp. Med. (2002)
- The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Kew, M.C., Yu, M.C., Kedda, M.A., Coppin, A., Sarkin, A., Hodkinson, J. Gastroenterology (1997)
- Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Fong, T.L., Valinluck, B., Govindarajan, S., Charboneau, F., Adkins, R.H., Redeker, A.G. Gastroenterology (1994)
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M.H., Albrecht, J. Gastroenterology (2002)
- Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Poynard, T., Marcellin, P., Lee, S.S., Niederau, C., Minuk, G.S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., Albrecht, J. Lancet (1998)
- Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Fargion, S., Fracanzani, A.L., Piperno, A., Braga, M., D'Alba, R., Ronchi, G., Fiorelli, G. Hepatology (1994)
- Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion. Noda, K., Yoshihara, H., Suzuki, K., Yamada, Y., Kasahara, A., Hayashi, N., Fusamoto, H., Kamada, T. Alcohol. Clin. Exp. Res. (1996)
- Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Dolan, K.A., Shearer, J., White, B., Zhou, J., Kaldor, J., Wodak, A.D. Addiction (2005)
- Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Raison, C.L., Broadwell, S.D., Borisov, A.S., Manatunga, A.K., Capuron, L., Woolwine, B.J., Jacobson, I.M., Nemeroff, C.B., Miller, A.H. Brain Behav. Immun. (2005)
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.H., Albrecht, J. N. Engl. J. Med. (1998)
- The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Love, R.A., Parge, H.E., Wickersham, J.A., Hostomsky, Z., Habuka, N., Moomaw, E.W., Adachi, T., Hostomska, Z. Cell (1996)
- The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. Alter, M.J., Margolis, H.S., Krawczynski, K., Judson, F.N., Mares, A., Alexander, W.J., Hu, P.Y., Miller, J.K., Gerber, M.A., Sampliner, R.E. N. Engl. J. Med. (1992)
- Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Silvie, O., Rubinstein, E., Franetich, J.F., Prenant, M., Belnoue, E., Rénia, L., Hannoun, L., Eling, W., Levy, S., Boucheix, C., Mazier, D. Nat. Med. (2003)
- Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance. Abid, K., Quadri, R., Negro, F. Science (2000)
- Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. Tanaka, K., Ikematsu, H., Hirohata, T., Kashiwagi, S. J. Natl. Cancer Inst. (1996)
- Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. Nouri Aria, K.T., Sallie, R., Sangar, D., Alexander, G.J., Smith, H., Byrne, J., Portmann, B., Eddleston, A.L., Williams, R. J. Clin. Invest. (1993)
- Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Hinrichsen, H., Benhamou, Y., Wedemeyer, H., Reiser, M., Sentjens, R.E., Calleja, J.L., Forns, X., Erhardt, A., Crönlein, J., Chaves, R.L., Yong, C.L., Nehmiz, G., Steinmann, G.G. Gastroenterology (2004)
- Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Kumar, U., Monjardino, J., Thomas, H.C. Gastroenterology (1994)
- The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Frank, C., Mohamed, M.K., Strickland, G.T., Lavanchy, D., Arthur, R.R., Magder, L.S., El Khoby, T., Abdel-Wahab, Y., Aly Ohn, E.S., Anwar, W., Sallam, I. Lancet (2000)
- Cyclophilin B escorts the hepatitis C virus RNA polymerase: a viral achilles heel? Heitman, J., Cullen, B.R. Mol. Cell (2005)
- Real-time detection system for quantification of hepatitis C virus genome. Takeuchi, T., Katsume, A., Tanaka, T., Abe, A., Inoue, K., Tsukiyama-Kohara, K., Kawaguchi, R., Tanaka, S., Kohara, M. Gastroenterology (1999)
- Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Nakagawa, M., Sakamoto, N., Tanabe, Y., Koyama, T., Itsui, Y., Takeda, Y., Chen, C.H., Kakinuma, S., Oooka, S., Maekawa, S., Enomoto, N., Watanabe, M. Gastroenterology (2005)
- Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Okuda, M., Li, K., Beard, M.R., Showalter, L.A., Scholle, F., Lemon, S.M., Weinman, S.A. Gastroenterology (2002)
- Viral error catastrophe by mutagenic nucleosides. Anderson, J.P., Daifuku, R., Loeb, L.A. Annu. Rev. Microbiol. (2004)
- Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. Tseng, C.T., Klimpel, G.R. J. Exp. Med. (2002)
- Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M.G., Houghton, M., Fiaccadori, F., Ferrari, C. J. Clin. Invest. (1996)
- La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation. Honda, M., Shimazaki, T., Kaneko, S. Gastroenterology (2005)
- Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens. Kuzushita, N., Gregory, S.H., Monti, N.A., Carlson, R., Gehring, S., Wands, J.R. Gastroenterology (2006)
- Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Dolganiuc, A., Oak, S., Kodys, K., Golenbock, D.T., Finberg, R.W., Kurt-Jones, E., Szabo, G. Gastroenterology (2004)
- Binding of hepatitis C virus to CD81. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G., Abrignani, S. Science (1998)
- Translational repression by a novel partner of human poly(A) binding protein, Paip2. Khaleghpour, K., Svitkin, Y.V., Craig, A.W., DeMaria, C.T., Deo, R.C., Burley, S.K., Sonenberg, N. Mol. Cell (2001)
- Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Tung, B.Y., Emond, M.J., Bronner, M.P., Raaka, S.D., Cotler, S.J., Kowdley, K.V. Gastroenterology (2003)
- Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Cramp, M.E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., Naoumov, N.V. Gastroenterology (2000)
- Specificity of the hepatitis C virus antibody ELISA in patients with hepatocellular carcinoma. Colombo, M., Grazia Rumi, M., Romeo, R., Sangiovanni, A. J. Natl. Cancer Inst. (1990)
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Féray, C., Caccamo, L., Alexander, G.J., Ducot, B., Gugenheim, J., Casanovas, T., Loinaz, C., Gigou, M., Burra, P., Barkholt, L., Esteban, R., Bizollon, T., Lerut, J., Minello-Franza, A., Bernard, P.H., Nachbaur, K., Botta-Fridlund, D., Bismuth, H., Schalm, S.W., Samuel, D. Gastroenterology (1999)
- Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Samuel, D., Bizollon, T., Feray, C., Roche, B., Ahmed, S.N., Lemonnier, C., Cohard, M., Reynes, M., Chevallier, M., Ducerf, C., Baulieux, J., Geffner, M., Albrecht, J.K., Bismuth, H., Trepo, C. Gastroenterology (2003)
- Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Wang, J.T., Wang, T.H., Sheu, J.C., Lin, J.T., Wang, C.Y., Chen, D.S. Gastroenterology (1992)
- Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Serfaty, L., Chazouillères, O., Pawlotsky, J.M., Andreani, T., Pellet, C., Poupon, R. Gastroenterology (1996)